Keyhani A - Search Results

1

Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.

Engel H, Drach J, Keyhani A, Jiang S, Van NT, Kimmel M, Sanchez-Williams G, Goodacre A, Andreeff M. Engel H, et al. Among authors: keyhani a. Leukemia. 1999 Apr;13(4):568-77. doi: 10.1038/sj.leu.2401359. Leukemia. 1999. PMID: 10214863

2

Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission.

Engel H, Goodacre A, Keyhani A, Jiang S, Van NT, Kimmel M, Sanchez-Williams G, Andreeff M. Engel H, et al. Among authors: keyhani a. Br J Haematol. 1997 Oct;99(1):64-75. doi: 10.1046/j.1365-2141.1997.3323151.x. Br J Haematol. 1997. PMID: 9359505 Free article.

3

Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia.

Schenk TM, Keyhani A, Bottcher S, Kliche KO, Goodacre A, Guo JQ, Arlinghaus RB, Kantarjian HM, Andreeff M. Schenk TM, et al. Among authors: keyhani a. Leukemia. 1998 May;12(5):666-74. doi: 10.1038/sj.leu.2400986. Leukemia. 1998. PMID: 9593263

4

Increased CD38 expression is associated with favorable prognosis in adult acute leukemia.

Keyhani A, Huh YO, Jendiroba D, Pagliaro L, Cortez J, Pierce S, Pearlman M, Estey E, Kantarjian H, Freireich EJ. Keyhani A, et al. Leuk Res. 2000 Feb;24(2):153-9. doi: 10.1016/s0145-2126(99)00147-2. Leuk Res. 2000. PMID: 10654451

5

Angiogenesis and leukemia.

Keyhani A, Jendiroba DB, Freireich EJ. Keyhani A, et al. Leuk Res. 2001 Aug;25(8):639-45. doi: 10.1016/s0145-2126(00)00161-2. Leuk Res. 2001. PMID: 11397467 Review. No abstract available.

6

Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines.

Pearlman M, Jendiroba D, Pagliaro L, Keyhani A, Liu B, Freireich EJ. Pearlman M, et al. Among authors: keyhani a. Leuk Res. 2003 Jul;27(7):617-26. doi: 10.1016/s0145-2126(02)00273-4. Leuk Res. 2003. PMID: 12681361

7

Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine.

Jendiroba DB, Klostergaard J, Keyhani A, Pagliaro L, Freireich EJ. Jendiroba DB, et al. Among authors: keyhani a. Leuk Res. 2002 Mar;26(3):301-10. doi: 10.1016/s0145-2126(01)00129-1. Leuk Res. 2002. PMID: 11792420

8

Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity.

Pearlman M, Jendiroba D, Pagliaro L, Keyhani A, Liu B, Freireich EJ, Travis E. Pearlman M, et al. Among authors: keyhani a. Cancer Chemother Pharmacol. 2003 Dec;52(6):477-81. doi: 10.1007/s00280-003-0655-3. Epub 2003 Jun 21. Cancer Chemother Pharmacol. 2003. PMID: 12827292

9

Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.

Pagliaro LC, Keyhani A, Liu B, Perrotte P, Wilson D, Dinney CP. Pagliaro LC, et al. Among authors: keyhani a. Urol Oncol. 2003 Nov-Dec;21(6):456-62. doi: 10.1016/s1078-1439(03)00032-2. Urol Oncol. 2003. PMID: 14693272

10

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.

Pagliaro LC, Keyhani A, Williams D, Woods D, Liu B, Perrotte P, Slaton JW, Merritt JA, Grossman HB, Dinney CP. Pagliaro LC, et al. Among authors: keyhani a. J Clin Oncol. 2003 Jun 15;21(12):2247-53. doi: 10.1200/JCO.2003.09.138. J Clin Oncol. 2003. PMID: 12805322 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters